Mark E. Tryniski, Director at CONMED CORP (CNMD), bought 5,000 shares at $41.15 ($206K) on 2017-03-06, disclosed to the SEC on 2017-03-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| CNMD | SELL | 2021-11-08 | $3.9M | — | Filing → |
| CNMD | SELL | 2021-02-23 | $427K | — | Filing → |
| CNMD | SELL | 2021-02-18 | $1.2M | — | Filing → |